adtralza
leo pharma a/s - tralokinumab - dermatita, atopică - alte preparate dermatologice - adtralza is indicated for the treatment of moderate to severe atopic dermatitis in adult and adolescent patients 12 years and older who are candidates for systemic therapy.
zineryt 40 mg/12 mg/ml
astellas pharma europe b.v. - olanda - combinatii (erythromycinum+zinci acetas) - pulb.+solv. sol. cut. - 40mg/12mg/ml - produse pt. trat. acneei de uz topic antiinfectioase pentru tratamentul acneei